Tradewinds Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Tradewinds Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$784	–	739
2025 Q3	$784	Hold	2	–	–	﹤0.01%	579
2025 Q2	$891	Hold	2	–	–	﹤0.01%	528
2025 Q1	$970	Hold	2	–	–	﹤0.01%	541
2024 Q4	$806	Hold	2	–	–	﹤0.01%	563
2024 Q3	$931	Sell	2 -2	-50%	-$961	﹤0.01%	520
2024 Q2	$1.88K	Buy	4 +2	+100%	+$868	﹤0.01%	448
2024 Q1	$837	Hold	2	–	–	﹤0.01%	472
2023 Q4	$814	Hold	2	–	–	﹤0.01%	396
2023 Q3	$696	Hold	2	–	–	﹤0.01%	411
2023 Q2	$704	Hold	2	–	–	﹤0.01%	399
2023 Q1	$631	Hold	2	–	–	﹤0.01%	407
2022 Q4	$578	Hold	2	–	–	﹤0.01%	441
2022 Q3	$1K	Hold	2	–	–	﹤0.01%	405
2022 Q2	$1K	Hold	2	–	–	﹤0.01%	420
2022 Q1	$1K	Buy	+2	New	+$475	﹤0.01%	755
2017 Q4	–	Sell	-81	Closed	-$12K	–	746
2017 Q3	$12K	Hold	81	–	–	0.01%	377
2017 Q2	$10K	Hold	81	–	–	0.01%	397
2017 Q1	$9K	Hold	81	–	–	0.01%	416
2016 Q4	$6K	Hold	81	–	–	﹤0.01%	433
2016 Q3	$7K	Hold	81	–	–	﹤0.01%	414
2016 Q2	$7K	Hold	81	–	–	0.01%	411
2016 Q1	$6K	Hold	81	–	–	﹤0.01%	456
2015 Q4	$10K	Hold	81	–	–	0.01%	384
2015 Q3	$8K	Hold	81	–	–	0.01%	394
2015 Q2	$10K	Hold	81	–	–	0.01%	410
2015 Q1	$10K	Hold	81	–	–	0.01%	377
2014 Q4	$10K	Hold	81	–	–	0.01%	386
2014 Q3	$9K	Hold	81	–	–	0.01%	388
2014 Q2	$8K	Hold	81	–	–	0.01%	402
2014 Q1	$6K	Hold	81	–	–	﹤0.01%	454
2013 Q4	$6K	Buy	+81	New	+$5.64K	﹤0.01%	432

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tradewinds Capital Management's VRTX Position: Q4 2025 in Review

Tradewinds Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 2 shares — an estimated $784 sold.

Tradewinds Capital Management first reported a position in VRTX in Q4 2013 and held it in 31 quarters. The position peaked at $12K in Q3 2017. 1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Tradewinds Capital Management reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Tradewinds Capital Management sold 2 Vertex Pharmaceuticals shares in Q4 2025, an estimated $784.
Tradewinds Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 31 quarters.
Tradewinds Capital Management's Vertex Pharmaceuticals position peaked at $12K in Q3 2017.
1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Tradewinds Capital Management's 13F filing for Q4 2025, filed 14 Jan 2026.